Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Annals of Oncology

• Publication date

  2015-02-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdv041PMID 25646366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histological Typing Of Lung And Pleural Tumours

  2016cited by this paper
• Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours.

  2014cited by this paper
• Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance.

  2013cited by this paper
• A Genomics-Based Classification of Human Lung Tumors

  2013cited by this paper
• Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumors.

  2013cited by this paper
• Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids

  2013cited by this paper
• Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

  2013cited by this paper
• Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801).

  2013cited by this paper
• Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System: A Comparison of Digital Image Analysis With Manual Methods

  2012cited by this paper
• mTOR/p70S6K in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

  2012cited by this paper
• Hitting the target: where do molecularly targeted therapies fit in the treatment scheduling of neuroendocrine tumours?

  2012cited by this paper
• Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

  2012cited by this paper
• RAMSETE: A single-arm, multicenter, single-stage phase II trial of RAD001 (everolimus) in advanced and metastatic silent neuro-endocrine tumours in Europe.

  2012cited by this paper
• Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study

  2012cited by this paper
• Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.

  2012cited by this paper
• Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases

  2012cited by this paper
• Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors

  2012cited by this paper
• Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach

  2012influential reference
• Neuroendocrine neoplasms of the pancreas: clinical, pathologic and cross-sectional imaging analysis according to the 4 th edition of the World Health Organization (WHO) classification of tumors of the digestive system

  2012cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2012cited by this paper
• Everolimus for Advanced Pancreatic Neuroendocrine Tumors

  2012cited by this paper
• mTOR/p70S6K in Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia

  2012cited by this paper
• Pazonet: A Phase II Trial of Pazopanib as a Sequencing Treatment in Progressive Metastatic Neuroendocrine Tumors (NETS) Patients (PTS), On Behalf of The Spanish Task Force for Nets (GETNE)

  2012cited by this paper
• Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: THE NET MANAGEMENT STUDY

  2012cited by this paper
• Multidirectional differentiation of Achaete-Scute homologue-1-defined progenitors in lung development and injury repair.

  2012cited by this paper
• What is DIPNECH?

  2012cited by this paper
• Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004.

  2011cited by this paper
• ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

  2011cited by this paper
• CT features of peripheral pulmonary carcinoid tumors.

  2011cited by this paper
• Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers.

  2011cited by this paper
• Tumorlets in familial history of bronchopulmonary carcinoid.

  2011cited by this paper
• Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2

  2011cited by this paper
• Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging.

  2011cited by this paper
• Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

  2011cited by this paper
• Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas.

  2011cited by this paper
• Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)

  2011cited by this paper
• Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview.

  2011cited by this paper
• Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases.

  2011cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2011cited by this paper
• Bronchopulmonary carcinoid tumors: long-term outcomes after resection.

  2011cited by this paper
• Partitioning of Bronchopulmonary Carcinoids in Two Different Prognostic Categories by Ki-67 Score

  2011cited by this paper
• Carcinoid lung tumors--incidence, treatment and outcomes: a population-based study.

  2011cited by this paper
• Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.

  2011cited by this paper
• Everolimus for advanced pancreatic neuroendocrine tumors.

  2011cited by this paper
• Management of carcinoid tumors.

  2010cited by this paper
• ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors

  2010cited by this paper
• The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems

  2010cited by this paper
• Long-term survival after surgical management of neuroendocrine hepatic metastases.

  2010cited by this paper
• Pulmonary assessment for general thoracic surgery.

  2010cited by this paper
• ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors

  2010cited by this paper
• The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide Scintigraphy

  2010cited by this paper
• Paraneoplastic syndromes secondary to neuroendocrine tumours.

  2010cited by this paper
• Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors Well-Differentiated Neuroendocrine Tumors of the Thorax ( Includes Lung and Thymus )

  2010influential reference
• Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases.

  2010cited by this paper
• Primary lung tumors in children and adolescents: a 90-year experience.

  2010cited by this paper
• Melanocytic bronchopulmonary carcinoid tumor in a patient with multiple endocrine neoplasia syndrome type 1: A case report with emphasis on intraoperative cytological findings

  2010cited by this paper
• Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

  2010cited by this paper
• ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung: Distribution and Impact on Survival

  2010cited by this paper
• Neuroendocrine tumors of the lung: an update.

  2010cited by this paper
• Spectrum of pulmonary neuroendocrine cell proliferation: diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids.

  2010cited by this paper
• 68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours

  2010cited by this paper
• Pulmonary Neuroendocrine Carcinomas

  2009cited by this paper
• Accomplishments in 2008 in the management of gastrointestinal neuroendocrine tumors.

  2009cited by this paper
• Tumors in the tracheobronchial tree: CT and FDG PET features.

  2009cited by this paper
• Tumorlets, Multicentric Carcinoids, Lymph-Nodal Metastases, and Long-Term Behavior in Bronchial Carcinoids

  2009cited by this paper
• Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

  2009cited by this paper
• Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours

  2009influential reference
• Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital.

  2009cited by this paper
• Activity of sunitinib in patients with advanced neuroendocrine tumors.

  2009cited by this paper
• 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid

  2009cited by this paper
• A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors

  2009cited by this paper
• Pulmonary neuroendocrine/carcinoid tumors

  2009cited by this paper
• Neuroendocrine carcinomas of the lung: a critical analysis.

  2009cited by this paper
• Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence.

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors:Echocardiography

  2009cited by this paper
• Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

  2009cited by this paper
• Bronchial Carcinoid Tumours in Children: Surgical Treatment and Outcome in a Single Institution

  2009cited by this paper
• Pulmonary tumours in the Netherlands: focus on temporal trends in histology and stage and on rare tumours

  2008cited by this paper
• The biological characterization of neuroendocrine tumors: The role of neuroendocrine markers

  2008cited by this paper
• Bronchopulmonary Carcinoid: Phenotype and Long-term Outcome in a Single-Institution Series of Italian Patients

  2008cited by this paper
• Pulmonary tumors in the Netherlands: focus on temporal trends in histology and stage and on rare tumors

  2008cited by this paper
• Neuroendocrine tumor epidemiology

  2008cited by this paper
• ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biotherapy

  2008influential reference
• ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations

  2008cited by this paper
• Risk factors associated with neuroendocrine tumors: A U.S.‐based case–control study

  2008cited by this paper
• Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.

  2008cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

  2008influential reference
• Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.

  2008cited by this paper
• One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

  2008cited by this paper
• Diagnosis of peripheral pulmonary carcinoid tumor using endobronchial ultrasound

  2008cited by this paper
• Bronchopulmonary neuroendocrine tumors

  2008cited by this paper
• Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.

  2008cited by this paper
• Clinical application of direct bronchial ultrasound to visualize and determine endobronchial tumor margins for surgical resection.

  2008cited by this paper
• Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study.

  2008cited by this paper
• Activity of sunitinib in patients with advanced neuroendocrine tumors.

  2008cited by this paper
• Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007

  2008cited by this paper
• Reclassification of Neuroendocrine Tumors Improves the Separation of Carcinoids and the Prediction of Survival

  2008cited by this paper
• Islet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases

  2008cited by this paper

• Update on diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

  2026cites this paper
• The impact of radioligand therapy on prognosis in patients with lung neuroendocrine tumors

  2026cites this paper
• Video‐Assisted Thoracoscopic Right Upper Lobe Sleeve Resection After Endobronchial Treatment of Bronchial Carcinoid: Case Report

  2026cites this paper
• Operated bronchial carcinoid tumors: impact of lymph node status and histological type on long-term outcomes.

  2026cites this paper
• Thymic Neuroendocrine Tumor Presenting With Cervical Lymphadenopathy: A Case Report and Diagnostic Challenge

  2025cites this paper
• Machine Learning Uncovers Novel Predictors of Peptide Receptor Radionuclide Therapy Eligibility in Neuroendocrine Neoplasms

  2025cites this paper
• Updates on Pulmonary Neuroendocrine Carcinoids: Progress and Perspectives

  2025cites this paper
• Emerging therapies and current standards in pulmonary carcinoid management

  2025cites this paper
• Survival advantage of radiotherapy and nomogram for patients with pulmonary neuroendocrine neoplasms: a propensity score-matched Surveillance, Epidemiology, and End Results database study

  2025cites this paper
• Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behavior

  2025cites this paper
• Raising the bar: evaluating quality and consistency in clinical guidelines for surgical management of pulmonary carcinoid

  2025cites this paper
• Personal Health Record Software for Neuroendocrine Tumors: Patient-Centered Design Approach

  2025cites this paper
• Digital Immunophenotyping of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Subtypes With Specific Tumor-Immune Microenvironment Features

  2025cites this paper
• Right Ventricular Metastasis in a Patient with Stage IV Small Bowel Neuroendocrine Tumor – A Case Report

  2025cites this paper
• An intelligent method for identifying location of tumor with lung electrical impedance tomography

  2025cites this paper
• Primary Typical Carcinoid Tumor of the Sphenoid Sinus: Case Report and Literature Review.

  2025cites this paper
• Sleeve Resection With or Without Parenchymal Resection for Proximal Bronchial Carcinoids: A Retrospective Analysis of Recurrence and Lymph Node Involvement

  2025cites this paper
• Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in lung carcinoid patients after receiving curative surgery. A multicentre study

  2025cites this paper
• Genetic insight into lung neuroendocrine tumors: Notch and Wnt signaling pathways as potential targets

  2025cites this paper
• Theranostics in Lung Neuroendocrine Tumors.

  2025cites this paper
• A 7-Year-Old Girl With Multiple Pulmonary Nodules.

  2025cites this paper
• Bronchial atypical carcinoid in the truncus intermedius persistently controlled by PDT following transbronchial resection instead of surgery: A case report.

  2025cites this paper
• Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids

  2025cites this paper
• Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies.

  2025cites this paper
• Current Management Strategies for Patients With Gastrointestinal and Pulmonary Neuroendocrine Tumors

  2025cites this paper
• Clinical needs and pathology’s answers in neuroendocrine neoplasms of the lung

  2025cites this paper
• Radiomic and Clinical–Pathological Factors Predictive of Postoperative Recurrence in Lung Neuroendocrine Tumors: A Pilot Study

  2025cites this paper
• Outcomes of Lobar and Sublobar Resection for Clinical Stage I Lung Neuroendocrine Tumors: An ENETS Center of Excellence Experience

  2025cites this paper
• Neuroendocrine Tumor of the Terminal Ileum Presenting as Refractory Crohn's Disease: A Diagnostic Challenge

  2025cites this paper
• [When salvage surgery for apparent "recurrence" of small-cell lung cancer leads to prolonged survival while correcting the initial diagnosis].

  2025cites this paper
• Beyond the usual – Atypical imaging presentation in lung cancer and implications for TNM-staging

  2025cites this paper
• Learning the cellular origins across cancers using single-cell chromatin landscapes

  2025cites this paper
• Lung Carcinoids in Adolescents and Young Adults (AYAs): A Still Overlooked Clinical Entity

  2025influential citation
• Pathology, molecular biology, medical oncology, and radiotherapy implications of lung neuroendocrine neoplasm classification: a multidisciplinary perspective

  2025cites this paper
• Thymic Neuroendocrine Tumors: Evolving Insights and Innovative Approaches

  2025cites this paper
• Paraneoplastic Cushing Syndrome Secondary to an Atypical Carcinoid Tumor of the Lung: A Rare Diagnostic Challenge

  2025cites this paper
• Contemporary Incidence and Survival of Lung Neuroendocrine Neoplasms

  2025cites this paper
• Smoking Adversely Affects Survival of Metastatic Lung Carcinoid Patients: Analysis of a Large International Audit and Prognostic Models for Metastasis-Free Survival and Overall Survival

  2025cites this paper
• Factors Influencing Costs of Cancer Care for Patients with Neuroendocrine Neoplasms

  2025influential citation
• Pathological & radiological variables in the diagnosis of bronchopulmonary carcinoids (BPCs) with a focus on Antigen Kiel 67 (Ki-67) proliferation index.

  2025cites this paper
• Neoadjuvant Bronchoscopic Photodynamic Therapy to Facilitate Airway and Parenchymal Sparing Lobectomies in Two Patients with Central Airway Neuroendocrine Tumors: A Patient Centered Approach.

  2025cites this paper
• Endocrine paraneoplastic syndromes in lung cancer: A call for clinical vigilance (Review)

  2025cites this paper
• Neuroendocrine Neoplasms of the Lungs, Thyroid, and Thymus

  2025influential citation
• Gender Perspective in Lung Neuroendocrine Tumors: A Critical Review

  2025influential citation
• Pathological Characteristics of Neuroendocrine Neoplasms in Sri Lankan Settings: A Retrospective Study

  2025cites this paper
• Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung

  2025cites this paper
• Surgical Management of Pulmonary Typical Carcinoids: A Single-Centre Experience Comparing Anatomical and Non-Anatomical Resections

  2025cites this paper
• Optimizing Lung Cancer Diagnostics: Insights from a Fast-Track Program in a Complex Healthcare Setting

  2025cites this paper
• Rare epithelial gastric cancers: a review of the current treatment knowledge

  2025cites this paper
• Bronchial Carcinoid Tumors in Children and Adolescents

  2025influential citation
• Prognostic Factors in Pulmonary Neuroendocrine Tumors’ Treatment: A Single-center Experience

  2025cites this paper
• Lobectomy versus sub-lobar resection for special type non-small cell lung cancer ≤2 cm

  2025cites this paper
• Implications of surgical intervention in patients with metastatic pulmonary carcinoid tumors: a SEER-based population study and propensity score matching comparative analysis

  2025cites this paper
• Development and evaluation of a multivariable prediction model for overall survival in advanced stage pulmonary carcinoid using machine learning.

  2025cites this paper
• Diagnostic challenges in pulmonary hamartomas: a case series

  2025cites this paper
• Survival following resection of 10244 lung neuroendocrine tumours: a population study.

  2025cites this paper
• Ectopic Cushing's syndrome in a patient with DIPNECH and metastatic lung carcinoid.

  2025cites this paper
• Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor.

  2025cites this paper
• Pulmonary Carcinoids: Diagnostic and Therapeutic Approach

  2025influential citation
• Immune-Checkpoint Inhibitors in Lung Neuroendocrine Tumors – A Systematic Review and Meta-Analysis

  2025cites this paper
• Well-Differentiated Lung Neuroendocrine Tumor Masquerading as Metastatic Medullary Thyroid Cancer

  2025cites this paper
• Population-Based Evidence of Familial Clustering in Pulmonary Carcinoid Tumors: Insights From the Utah Population Database

  2025cites this paper
• Imaging patterns and recommendations for diagnosis, staging, and management of lung cancer

  2025cites this paper
• Identification of defined molecular subgroups based on immunohistochemical analyses and potential therapeutic vulnerabilities of pulmonary carcinoids.

  2024cites this paper
• Pediatric Neuroendocrine Tumors in Denmark: Incidence, Management, and Outcome From 1995 to 2020

  2024cites this paper
• Differential cytological diagnosis of typical and atypical lung carcinoid

  2024cites this paper
• Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumors.

  2024cites this paper
• Constructing a folate metabolism gene signature for predicting prognosis in pulmonary neuroendocrine carcinomas

  2024cites this paper
• The Importance of Advanced Imaging in Diagnosing and Differentiating Lung Carcinoid Tumors From Pulmonary TB and Upper Respiratory Infections

  2024cites this paper
• Neuroendocrine Carcinoid Lung Tumor: A Case Series of an Indolent Tumor

  2024cites this paper
• Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells

  2024cites this paper
• OTP, CD44, and Ki-67: A prognostic marker panel for relapse free survival in patients with surgically resected pulmonary carcinoid.

  2024cites this paper
• TERT Expression and Clinical Outcome in Pulmonary Carcinoids

  2024cites this paper
• Clinical Predilection Features of Middle Ear Adenomatous Neuroendocrine Tumors: A Review of 10 Patients and a Special Case Is Attached.

  2024cites this paper
• Quel bilan anatomo-pathologique ?

  2024cites this paper
• Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid

  2024cites this paper
• Unusual Radiological Presentation of a Typical Carcinoid in a Young Female With High-Grade Intermittent Fever: A Case Report

  2024cites this paper
• PET/MRI: pictorial review of hepatobiliary and pancreatic applications

  2024cites this paper
• The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives

  2024cites this paper
• Severe Ectopic Adrenocorticotropic Hormone Syndrome Due to Pulmonary Carcinoid Tumor: A Case Report and Literature Review

  2024cites this paper
• Neuroendokrine Tumoren der Lunge: State of the Art

  2024cites this paper
• Right Upper Lobe Large Cell Neuroendocrine Carcinoma with Atypical Carcinoid Features: Case Report

  2024cites this paper
• Atypical Cerebral Carcinoids Treated with Hippocampal-Sparing Whole Brain Radiotherapy

  2024cites this paper
• Differentiating lung neuroendocrine neoplasms from tumor-like infection using CT in patients with ectopic ACTH syndrome

  2024influential citation
• Management of typical and atypical metastatic lung carcinoids: present and future perspectives

  2024cites this paper
• Is surgery of atypical carcinoid possible during active pulmonary tuberculosis?

  2024cites this paper
• Radiolabeled Somatostatin Analogs for Cancer Imaging.

  2024cites this paper
• Syndrome de Cushing paranéoplasique par sécrétion ectopique d’hormone adrénocorticotrope

  2024cites this paper
• Central airway carcinoid tumor mimicking chronic asthma and necessitating pneumonectomy: A case report

  2024cites this paper
• Exploring the multifaceted antitumor activity of axitinib in lung carcinoids

  2024cites this paper
• Real world results of locally advanced and metastatic lung cancer patients treated with platinum doublet chemotherapy in first line: Moroccan cohort

  2024cites this paper
• Advances in Diagnosis and Treatment of Pancreatic Endocrine Tumors

  2024cites this paper
• Endoscopic treatment of endobronchial carcinoid: technical considerations and experience in interventional pulmonology

  2024cites this paper
• Segmentectomy and wedge resection are equivalent for the treatment of early-stage pulmonary carcinoid tumors: A retrospective cohort study

  2024cites this paper
• Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study

  2024cites this paper
• Evaluating the usefulness of plasma chromogranin A measurement in cyclic ACTH-dependent Cushing’s syndrome

  2024cites this paper
• The presentation pattern and surgical strategies in bronchopulmonary carcinoid tumors: a multicenter experience in a low-income country

  2024cites this paper
• The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions

  2024cites this paper
• Management of Central Airway Obstruction. An American College of Chest Physicians Clinical Practice Guideline.

  2024cites this paper
• Impact of lymph node involvement in pulmonary carcinoids: a narrative review

  2024cites this paper